Lupin Limited has informed the Exchange regarding a press release dated January 18, 2024, titled "Lupin Receives Approval from U.S. FDA for Febuxostat Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated January 18, 2024, titled "Lupin Receives Approval from U.S. FDA for Febuxostat Tablets.".